Published in Antimicrob Agents Chemother on June 01, 1985
Development and qualification of a pharmacodynamic model for the pronounced inoculum effect of ceftazidime against Pseudomonas aeruginosa. Antimicrob Agents Chemother (2008) 1.26
Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1986) 1.12
Increased killing of staphylococci and streptococci by daptomycin compared with cefazolin and vancomycin in an in vitro peritoneal dialysate model. Antimicrob Agents Chemother (2003) 1.09
Influence of carbon dioxide on growth and antibiotic susceptibility of coagulase-negative staphylococci cultured in human peritoneal dialysate. J Clin Microbiol (1990) 1.06
In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids. Antimicrob Agents Chemother (1989) 0.89
Susceptibility testing of bacteria recovered from patients with peritonitis complicating continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1992) 0.79
Effect of peritoneal dialysis fluid and pH on bactericidal activity of ciprofloxacin. Antimicrob Agents Chemother (1987) 0.78
Peritoneal fluid titer test for peritoneal dialysis-related peritonitis. Antimicrob Agents Chemother (2004) 0.75
The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis. Eur J Clin Microbiol Infect Dis (2015) 0.75
In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid. Eur J Clin Microbiol (1983) 8.38
Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro. Antimicrob Agents Chemother (1975) 3.43
Peritonitis in continuous ambulatory peritoneal dialysis. Laboratory and clinical studies. Lancet (1982) 2.30
Inhibition of the antibacterial activity of gentamicin by urine. J Infect Dis (1976) 1.78
Pseudomonas peritonitis and continuous ambulatory peritoneal dialysis. Arch Intern Med (1982) 1.47
Pharmaceutics of penicillin. J Pharm Sci (1962) 1.24
Peritonitis in continuous ambulatory peritoneal dialysis. J Antimicrob Chemother (1982) 1.14
Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet (1983) 1.04
Peritonitis in children undergoing continuous ambulatory peritoneal dialysis. Pediatrics (1983) 0.99
Effect of peritoneal dialysis solution on the antimicrobial activity of cephalosporins. Nephron (1982) 0.94
Peritonitis in children receiving continuous ambulatory peritoneal dialysis. Pediatr Infect Dis (1983) 0.91
MECHANISM OF DEGRADATION OF PENICILLIN G IN ACIDIC SOLUTION. J Pharm Sci (1965) 0.90
The mode of action of antibiotics on gram-negative bacilli. Arch Intern Med (1971) 0.90
Continuous ambulatory peritoneal dialysis. Three years' experience at the Mayo Clinic. Mayo Clin Proc (1983) 0.84
A newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia. N Engl J Med (1990) 4.46
In vitro activity of CI-919 (AT-2266), an oral antipseudomonal compound. Antimicrob Agents Chemother (1983) 4.00
5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann Intern Med (1972) 3.55
Campylobacter gastroenteritis in children. J Pediatr (1979) 3.42
Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol (1993) 2.85
Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med (1995) 2.74
Yersinia enterocolitica gastroenteritis: a prospective study of clinical, bacteriologic, and epidemiologic features. J Pediatr (1980) 2.73
Polymerase chain reaction-based restriction fragment length polymorphism analysis of a fragment of the ribosomal operon from Rochalimaea species for subtyping. J Clin Microbiol (1993) 2.41
Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother (1979) 2.40
Penicillin-insensitive pneumococci. Case report and review. Am J Dis Child (1979) 2.25
Identification of toxigenic Clostridium difficile by counterimmunoelectrophoresis. J Clin Microbiol (1980) 2.24
Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol (1989) 2.23
Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol (2009) 2.20
Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med (1992) 2.20
Relationship between superoxide dismutase and pathogenic mechanisms of Listeria monocytogenes. Infect Immun (1979) 2.15
Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol (1989) 2.15
Efficacy of cold enrichment techniques for recovery of Yersinia enterocolitica from human stools. J Clin Microbiol (1979) 2.13
All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett (1990) 2.05
Ribavirin: adverse drug reactions, 1986 to 1988. Pediatr Infect Dis J (1990) 1.98
Application of four methods to the study of the susceptibility of yeast to 5-fluorocytosine. Antimicrob Agents Chemother (Bethesda) (1970) 1.97
A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission? Infect Control Hosp Epidemiol (2000) 1.86
Bacteremia due to Rochalimaea henselae in a child: practical identification of isolates in the clinical laboratory. J Clin Microbiol (1993) 1.82
Prevalence of thymidine-dependent Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol (1987) 1.80
Nosocomial acquisition of Burkholderia gladioli in patients with cystic fibrosis. Am J Respir Crit Care Med (1997) 1.79
Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. J Pediatr (1971) 1.75
Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrob Agents Chemother (1982) 1.74
Comparison of sedimentation and flotation techniques for identification of Cryptosporidium sp. oocysts in a large outbreak of human diarrhea. J Clin Microbiol (1985) 1.73
The organism causing bacillary angiomatosis, peliosis hepatis, and fever and bacteremia in immunocompromised patients. N Engl J Med (1991) 1.72
The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr (1981) 1.70
Use of a ribosomal RNA gene probe for the epidemiological study of methicillin and ciprofloxacin resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1990) 1.65
Comparison of polyclonal antiserum versus monoclonal antibodies for the rapid diagnosis of influenza A virus infections by immunofluorescence in clinical specimens. J Clin Microbiol (1985) 1.65
Clinical manifestations of coxsackievirus infections in children. Am J Dis Child (1974) 1.62
Evaluation of a lysis direct plating method for pediatric blood cultures. J Clin Microbiol (1985) 1.61
Experimental infection of young specific pathogen-free cats with Bartonella henselae. J Infect Dis (1997) 1.61
In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine, and clotrimazole (Bay 5097). Appl Microbiol (1971) 1.60
Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. J Clin Invest (1982) 1.59
Influences of media and inocula on the in vitro susceptibility of Haemophilus influenzae to co-trimoxazole, ampicillin, penicillin, and chloramphenicol. Antimicrob Agents Chemother (1975) 1.58
Evaluation of Bactogen and Phadebact for detection of Haemophilus influenzae type b antigen in cerebrospinal fluid. J Clin Microbiol (1982) 1.50
Carbenicillin: a clinical and laboratory evaluation. Ann Intern Med (1970) 1.48
Vitamin A levels in children with measles in Long Beach, California. J Pediatr (1992) 1.42
In vitro activity of BMY-28142 against pediatric pathogens, including isolates from cystic fibrosis sputum. Antimicrob Agents Chemother (1985) 1.42
Evaluation of the Phadebact CSF test for detection of the four most common causes of bacterial meningitis. J Clin Microbiol (1983) 1.40
The diagnostic and therapeutic approach to acute bronchiolitis in hospitalized children in Israel: a nationwide survey. Isr Med Assoc J (2000) 1.40
A survey of current Israeli practices and approach to partially treated meningitis in children. Isr J Med Sci (1995) 1.39
Septicemia and meningitis caused by Helicobacter cinaedi in a neonate. J Clin Microbiol (1993) 1.39
Activity of newer aminoglycosides and carbenicillin, alone and in combination, against gentamicin-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother (1976) 1.37
Immunization today--a review. Can Med Assoc J (1973) 1.37
Adverse reactions to 1975 bivalent influenza vaccine in children. Can Med Assoc J (1977) 1.34
Is anti-Pseudomonas therapy warranted in acute respiratory exacerbations in children with cystic fibrosis? J Pediatr (1980) 1.34
Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype O:3. Antimicrob Agents Chemother (1977) 1.34
Murine antibody responses distinguish Rochalimaea henselae from Rochalimaea quintana. J Clin Microbiol (1992) 1.34
Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. J Pediatr (1981) 1.33
Interaction of ketoconazole with rifampin and isoniazid. N Engl J Med (1984) 1.32
Passive immunization in experimental Herpesvirus hominis infection of newborn mice. Infect Immun (1975) 1.31
Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution. Antimicrob Agents Chemother (1980) 1.30
Cefuroxime versus ampicillin plus chloramphenicol in childhood bacterial meningitis: a multicenter randomized controlled trial. J Pediatr (1986) 1.28
Meningococcal colonization and infection in children and their household contacts. Am J Epidemiol (1979) 1.27
The glomerulopathy of congenital syphilis--an immune deposit disease. J Pediatr (1972) 1.27
In vitro activity of BMY-28100 against common isolates from pediatric infections. Antimicrob Agents Chemother (1987) 1.26
Augmentation of the antibacterial activity of magainin by positive-charge chain extension. Antimicrob Agents Chemother (1992) 1.25
Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. Pneumococcus Study Group. J Infect Dis (1993) 1.24
Oral antibiotic therapy of skeletal infections in children. Pediatrics (1980) 1.23
Detection of Bartonella (Rochalimaea) quintana by routine acridine orange staining of broth blood cultures. J Clin Microbiol (1994) 1.23
Clinical profile of pediatric patients hospitalized with respiratory syncytial virus infection. Clin Pediatr (Phila) (1993) 1.21
Respiratory syncytial virus puzzle: clinical features, pathophysiology, treatment, and prevention. J Pediatr (1992) 1.20
Is Clostridium difficile pathogenic in infants? J Pediatr (1982) 1.19
Rapid identification of herpes simplex virus in tissue culture by direct immunofluorescence. J Lab Clin Med (1971) 1.19
Laboratory identification of Torulopsis glabrata: typical appearance on routine bacteriological media. Appl Microbiol (1970) 1.18
Exchange transfusion in the treatment of hepatic coma. J Pediatr (1969) 1.18
Nosocomial infantile gastroenteritis associated with minirotavirus and calicivirus. J Pediatr (1978) 1.18
Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin. Antimicrob Agents Chemother (1981) 1.17
Single-dose pharmacokinetics of aztreonam in pediatric patients. Antimicrob Agents Chemother (1984) 1.16
Parainfluenza virus immunofluorescence. In vitro and clinical application of the direct method. Pediatrics (1971) 1.15
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy. Eur Respir J (2005) 1.14
Intradermal influenza immunization. Experience with Hong Kong vaccine. Am Rev Respir Dis (1971) 1.13
Immunocytochemical identification of Rochalimaea henselae in bacillary (epithelioid) angiomatosis, parenchymal bacillary peliosis, and persistent fever with bacteremia. Am J Surg Pathol (1992) 1.12
Pharmacokinetics of single-dose oral ciprofloxacin in patients undergoing chronic ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1986) 1.12
Antimicrobial susceptibility of Aeromonas species isolated from patients with diarrhea. Antimicrob Agents Chemother (1986) 1.11
Torulopsis glabrata--an opportunistic pathogen in man. N Engl J Med (1970) 1.10
In vitro sensitivity of Salmonella to ten antimicrobial agents including sulfamethoxazole and trimethoprim, alone and in combination. Antimicrob Agents Chemother (1973) 1.09
Evidence of reproductive failure and lack of perinatal transmission of Bartonella henselae in experimentally infected cats. Vet Immunol Immunopathol (1998) 1.08
Activities of eight new beta-lactam antibiotics and seven antibiotic combinations against Neisseria meningitidis. Antimicrob Agents Chemother (1982) 1.07
In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrob Agents Chemother (1982) 1.07
Differentiation of Haemophilus spp. in Respiratory isolate cultures by an indole spot test. J Clin Microbiol (1982) 1.06
Daily periodicity of susceptibility of mice to pneumococcal infection. Nature (1969) 1.06
Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative study. J Pediatr (1972) 1.05
Variables influencing the in vitro susceptibilities of herpes simplex viruses to antiviral drugs. Antimicrob Agents Chemother (1974) 1.03
Structure-function studies of amphiphilic antibacterial peptides. J Med Chem (1993) 1.02
In vitro susceptibility of Haemophilus influenzae to sulfamethoxazole-trimethoprim and cefaclor, cephalexin, and cephradine. Antimicrob Agents Chemother (1978) 1.02
An outbreak of severe pneumonia due to respiratory syncytial virus in isolated Arctic populations. Am J Epidemiol (1975) 1.02
Progressive cough associated with lymphocytic leukemoid reaction in an infant. J Pediatr (1980) 1.01
Pneumonia caused by a newly recognized pseudomonad in a child with chronic granulomatous disease. J Clin Microbiol (1990) 1.00